Susquehanna International Group’s Amplify Treatments, Testing and Advancements ETF GERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-46,695
| Closed | -$850K | – | 6859 |
|
|
2024
Q2 | $850K | Buy |
46,695
+5,382
| +13% | +$98K | ﹤0.01% | 2773 |
|
|
2024
Q1 | $761K | Buy |
41,313
+7,173
| +21% | +$132K | ﹤0.01% | 2976 |
|
|
2023
Q4 | $668K | Buy |
34,140
+12,994
| +61% | +$254K | ﹤0.01% | 3441 |
|
|
2023
Q3 | $378K | Buy |
21,146
+9,209
| +77% | +$165K | ﹤0.01% | 3781 |
|
|
2023
Q2 | $246K | Buy |
+11,937
| New | +$246K | ﹤0.01% | 4436 |
|
|
2023
Q1 | – | Sell |
-49,144
| Closed | -$1.1M | – | 6935 |
|
|
2022
Q4 | $1.1M | Buy |
49,144
+9,966
| +25% | +$223K | ﹤0.01% | 2216 |
|
|
2022
Q3 | $812K | Buy |
39,178
+5,303
| +16% | +$110K | ﹤0.01% | 2829 |
|
|
2022
Q2 | $788K | Buy |
33,875
+20,700
| +157% | +$482K | ﹤0.01% | 2747 |
|
|
2022
Q1 | $361K | Buy |
+13,175
| New | +$361K | ﹤0.01% | 4122 |
|